The molecular characteristics of the MCD subtype and the ABC subtype, such as deletion of CDKN2A, BCL2 overexpression, activation of BCR and NF-κB signaling pathways, may be the cause and result of lymphoma losing homing ability. This evidence concerns the gene BCR and aneurysmal bone cyst.